Drug Delivery for Cardiovascular Diseases

Drug delivery for cardiovascular diseases aims to improve the efficacy and safety of therapeutics targeting heart conditions. Targeted drug delivery systems can deliver drugs directly to the site of action, such as the heart or blood vessels, minimizing systemic side effects. Nanoparticle-based drug delivery systems can improve the bioavailability and efficacy of cardiovascular drugs by enhancing their stability and targeting specific tissues. Stents coated with drugs can prevent restenosis (re-narrowing of blood vessels) by releasing drugs that inhibit cell proliferation at the site of stent placement. Long-acting or extended-release formulations can maintain therapeutic drug levels over an extended period, reducing the frequency of dosing. Gene delivery systems can be used to deliver therapeutic genes to target cells in the heart, offering potential for treating genetic cardiovascular disorders. Delivery of stem cells or progenitor cells to the heart can promote tissue repair and regeneration in conditions like myocardial infarction. Continuous infusion pumps can deliver drugs intravenously in controlled doses, especially in critical care settings. Formulations that improve the oral bioavailability of cardiovascular drugs can enhance patient compliance and convenience. Biodegradable polymers are used in drug delivery systems to deliver drugs over time and then degrade harmlessly in the body.

    Related Conference of Drug Delivery for Cardiovascular Diseases

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Drug Delivery for Cardiovascular Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in